parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.01 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced, including microglia; strongest in neutrophils	0.75
chemistry Open Targets	hard to drug	0.27
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	no papers tie it to Parkinson's yet	1.00
pathways Reactome	in no curated pathway	0.00

No case: the score is under the bar. Receipt 9788

receipt 9796: SASH3 in dopamine neurons, braak

power: full sample -0.19 (p 0.460, n 18), 95% CI -0.60 to +0.31. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.21 (p 0.413, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.21 (p 0.413, n 18). could be the mix.
skeptic: leave-one-out range -0.34 to -0.10, sign flips 0; without severely affected donors -0.19 (p 0.460, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for SASH3 in dopamine neurons.

case closed: nothing better to follow up.

receipt 9795: SASH3 in microglia, braak

power: full sample -0.46 (p 0.056, n 18), 95% CI -0.76 to +0.01. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.51 (p 0.032, n 18). holds up.
composition: microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.45 (p 0.059, n 18). could be the mix.
skeptic: leave-one-out range -0.64 to -0.39, sign flips 0; without severely affected donors -0.46 (p 0.056, n 18). robust.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for SASH3 in microglia.

case closed: nothing better to follow up.

loading the receipts